Panbela Therapeutics Inc. (PBLA)
0.36
-0.00 (-0.03%)
At close: Mar 03, 2025, 9:42 AM
Panbela Therapeutics Cash Flow Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
| Net Income | -25.26M | -34.93M | -10.13M | -4.77M | -6.2M | -5.91M | -10.37M | -5.11M | -4.93M | -107.04K | -212.02K | 247.38K | -138.31K |
| Depreciation & Amortization | n/a | n/a | n/a | 114K | 2.07M | n/a | n/a | 28K | 28K | 9.58K | 8.79K | 5.64K | 3.1K |
| Stock-Based Compensation | 823K | 1.09M | 1.29M | 1.21M | 1.09M | 1.28M | 1.73M | 902K | 976K | 196.00 | 600.00 | 600.00 | 600.00 |
| Other Working Capital | -7.71M | -1.69M | 1.51M | 559K | -113K | 134K | 257K | 620K | -655K | -17.15K | 6K | 2.56K | 4.4K |
| Other Non-Cash Items | -162K | 18.01M | 605K | -103K | 2.18M | 1.75M | 5.3M | 12K | 1M | 33.98K | 114.38K | 116.16K | 169.9K |
| Deferred Income Tax | n/a | n/a | n/a | -114K | -2.07M | n/a | n/a | n/a | -1M | n/a | n/a | -833 | n/a |
| Change in Working Capital | -647K | 559K | 2.14M | -188K | 188K | 494K | -62K | 1.77M | 26K | 52.04K | 52.86K | -331.83K | -108.33K |
| Operating Cash Flow | -25.25M | -15.28M | -6.7M | -3.85M | -2.74M | -2.39M | -3.4M | -2.4M | -3.9M | -11.45K | -35.39K | 37.11K | -73.04K |
| Capital Expenditures | n/a | -660K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5.12K | n/a | -9.53K |
| Acquisitions | n/a | 4K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 500K | n/a | n/a | 19.12K | n/a |
| Other Investing Acitivies | 400K | -656K | -540K | n/a | n/a | n/a | n/a | n/a | 500.00 | 124.72K | -5.12K | 833.00 | n/a |
| Investing Cash Flow | 400K | -656K | -540K | n/a | n/a | n/a | n/a | n/a | 500K | 124.72K | -5.12K | 19.12K | -9.53K |
| Debt Repayment | -1.65M | n/a | n/a | n/a | 624K | 1.31M | 3.06M | n/a | n/a | 2.39M | n/a | 6.85K | 8.9K |
| Common Stock Repurchased | -10K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 4.75M | 5K | 1.04M | -637K | n/a | n/a | 47K | 42K | 1.16M | -2.4M | -11.61K | n/a | n/a |
| Financial Cash Flow | 26.14M | 5.35M | 10.1M | 10.44M | 3.78M | 3.64M | 3.11K | 1.92K | 2.67K | -8.32K | -11.61K | 6.85K | 8.9K |
| Net Cash Flow | 1.29M | -10.58M | 2.85M | 6.57M | 1.04M | 1.25M | -286K | -487K | -729K | 104.95K | -52.12K | 63.09K | -73.67K |
| Free Cash Flow | -25.25M | -15.94M | -6.7M | -3.85M | -2.74M | -2.39M | -3.4M | -2.4M | -3.9M | -11.45K | -40.51K | 37.11K | -82.57K |